The development and optimization of an efficient conjugation process involves identifying the critical quality attributes and monitoring critical process parameters.
Jesse Novak
Advertisement
Jesse Novak is a bioconjugation scientist at Abzena.
Articles by Jesse Novak
Advertisement
Latest Updated Articles
QbD in the Development of ADCs with PBD Dimer WarheadsPublished: September 1st 2018 | Updated:
Advertisement
Advertisement
Trending on BioPharm International
1
Why Flexibility and Commercial Viability Must Be Built-in Early for Scaling CGTs
2
Industry Leaders Detail Transformational Strategies to Mainstream CAR-T Care
3
How Rentschler Biopharma’s New Platforms Aim to Accelerate Biologics Development in Asia
4
Analyzing the Safety and Scope of Next-Generation Gene Editing Platforms
5
